AFP and hepatocellular carcinoma: Subgroup analysis revealed that additional benefit of serum AFP was significant in patients with cirrhosis from chronic hepatitis B and C. Association of high serum AFP level in HCC patients with hepatitis B infection has been reported.7 However, our results showed the benefit of serum AFP was only in cirrhotic chronic hepatitis B patients, but not in noncirrhotic cases.